Pharmacokinetics and disposition of the oxytocin receptor antagonist L- 368,899 in rats and dogs

Drug Metabolism and Disposition

Volumn 25, Issue 10, 1997, Pages 1113-1118

  Thompson, Kathryn L ^a   Vincent, Styliani H ^a   Miller, Randall R ^a   Colletti, Adria E ^a   Alvaro, Raul F ^a   Wallace, Michael A ^a   Feeney, William P ^a   Chiu, Shuet Hing Lee ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[[2 [2 AMINO 4 (METHYLSULFONYL)BUTYRAMIDO] 7,7 DIMETHYLBICYCLO[2.2.1]HEPTAN 1 YL]METHYL]SULFONYL] 4 (2 METHYLPHENYL)PIPERAZINE; OXYTOCIN ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DOG; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG HALF LIFE; DRUG METABOLISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PREMATURE LABOR; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; BORNANES; DOGS; FEMALE; HALF-LIFE; INJECTIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; MICROSOMES, LIVER; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OXYTOCIN; SEX FACTORS; TOCOLYTIC AGENTS;

ANIMALIA; CANIS FAMILIARIS;

EID: 0030846063     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. C. G. Nwaesei, D. C. Young, and J. M. Byrne: Preterm birth at 23-26 weeks' gestation: Is active obstetric management justified? Am. J Obstet. Genecol 157, 157-166 (1987).
2. S. Veen, M. H. Ens-Dokkum, A. M. Schreuder, S. P. Verloove-Vanhorick, R. Brand, and J. H. Ruys: Impairments, disabilities and handicaps of very preterm and very low-birthweight infants at five years of age. Lancet 338, 33-36 (1991).
3. S. N. Caritis: Treatment of preterm labor: a review of the therapeutic options. Drugs 26, 243-261 (1983).
4. A.-R. Fuchs, F. Fuchs, P. Husslein, and M. Soloff: Oxytocin receptors in the human uterus during pregnancy and parturition. Am. J. Obstet. Gynecol. 150, 734-741 (1984).
5. R. Chibbar, F. D. Miller, and B. F. Mitchell: Synthesis of oxytocin in amnion, chorion, and decidua may influence the timing of human parturition. J. Clin. Invest. 91, 185-192 (1993).
6. L. H. Anderson, J. Lyndrup, M. Akerlund, and P. Melin: Oxytocin receptor blockade: A new principle in the treatment of preterm labor. Am. J. Perinat. 6, 196-199 (1989).
7. T. M. Goodwin, R. H. Paul, H. Silver, M. Parsons, R. Chez, R. W. Spellacy, R. Hayashi, L. North, and R. Merriman: Safety and efficacy of the oxytocin antagonist atosiban in threatened preterm labor: Initial U. S. trial (abstract 298). Am. J. Obstet. Gynecol. 166, 359, (1992).
8. B. E. Evans, J. L. Leighton, K. E. Rittle, K. F. Gilbert, G. F. Lundell, N. P. Gould, D. W. Hobbs, R. M. DiPardo, D. F. Veber, D. J. Pettibone, B. V. Clineschmidt, P. S. Anderson, and R. M. Freidinger: Orally active, non-peptide oxytocin antagonists. J. Med. Chem. 35, 3919-3927 (1992).
9. D. J. Pettibone, B. V. Clineschmidt, M. T. Guidotti, E. V. Lis, D. R. Reiss, C. J. Woyden, M. G. Bock, B. E. Evans, R. M. Freidinger, D. J. Hobbs, D. F. Veber, P. D. Williams, S.-H. L. Chiu, K. L. Thompson, T. W. Schoin, P. K. S. D. Siegl, M. J. Kaufman, M. A. Cukierski, G. J. Haluska, M. J. Cook, and M. J. Novy: L-368,899, a potent orally-active oxytocin antagonist for potential use in preterm labor. Drug Dev. Res. 30, 129-142 (1993).
10. P. D. Williams, P. S. Andrerson, R. G. Ball, M. G. Bock, L. Carroll, S.-H. L. Chiu, B. V. Clineschmidt, J. C. Culberson, J. M. Erb, B. E. Evans, S. L. Fitzpatrick, R. M. Freidinger, M. J. Kaufman, G. F. Lundell, J. S. Murphy, J. M. Pawluczyk, D. S. Perlow, D. J. Pettibone, S. M. Pitzenberger, K. L. Thompson, and D. F. Veber: l-(((7.7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)hutyramindo)bicyclo[2.2.1] heptan-1(S)-yl)me(hyl)sulfonyl)-4-(2-methylphenyl)piperazine (L-368,899), an orally bioavailable non-peptide oxytocin antagonist with potential utility for managing preterm labor. J. Med. Chem. 37, 565-571 (1994).
11. K. C. Yeh, R. D. Small, and G. A Winchell: Pharmacokinetic evaluation of stable piecewise cubic polynomials as numerical intergration functions. J. Pharm. Sci. 76, S104 (1987).
12. L. Z. Benet, and R. L. Galeazzi: Noncompartmental determination of the steady-sate volume of distribution. J. Pharm. Sci. 68, 1071-1074 (1979).
13. R. Kato: Sex-related differences in drug metabolism. Drug Metab. Rev. 3, 1-32 (1974).
14. R. Kato, and Y. Yamazoe: Sex-dependent regulation of cytochrome P-450 expression In Frontiers in Biotransformation vol 2; Principles. Mechanisms and Biological Consequences of Induction (K. Ruckpaul and H. Heins, eds.), pp. 82-112. Taylor & Francis, New York, 1990.
15. D. J: Waxman: Regulation of liver-specific steroid metabolizing cytochrome P450: cholesterol 7α-hydroxylase, bile acid 6β-hydroxylases, and growth hormone-responsive steroid hormone hydrpxylases. J. Steroid Biochem. Mol. Biol. 43, 1055-1072 (1992).
16. J. H. Lin, M. China, I-W. Chen, J. A. Nishime, and K. J. Vastag: Sex-dependent pharmacokinetics of Indinavir: in vivo and in vitro evidence. Drug Metab. Dispos. 24, 1298-1306 (1996).
17. V. Kobliakov, N. Popova and L. Rossi: Regulation of the expression of the sex-specific isoforms of cytochrome P-450 in rat liver. Eur. J. Biochem. 195, 585-591 (1991).
18. C. Legraverend, A. Mode, S. Westin, A. Ström, H. Eguchi, P. Zaphiropoulos, and J. A. Gustafsson: Transcriptional regulation of rat P-450 2C gene subfamily members by the sexually dimorphic pattern of growth homone secretion. Mol. Endocrin. 6, 259-266 (1992).
19. D. J. Waxman, P. A. Ram, G. Notani, G. A. LeBlanc, J. A. Alberta, J. J. Morrissey, and S. S. Sundseth: Pituitary regulation of the male-specific steriod 6β-hydroxylase P-450 2a (gene product IIIA2) in adult rat liver. Suppression influence of growth hormone and thyroxine acting at a pretranslational level. Mol. Endocrin. 4, 447-454 (1990).
20. J. H. Lin: Dose-dependent pharmacokinetics: Experimental observations and theoretical considerations. Biopharm. Drug Dispos. 15, 1-31 (1994).